结核病总论英文_第1页
结核病总论英文_第2页
结核病总论英文_第3页
结核病总论英文_第4页
结核病总论英文_第5页
已阅读5页,还剩31页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

结核病总论英文第一页,共36页。tuberculosisfactoroftuberculosisincidencerising:HIVspread.TBstrainoccurdrugresistance.fluidpopulationincreasing.ManagementTBpatientnotperfect、preventionandcurenotefficiency.Poverty、populationincreasing.2第二页,共36页。etiologyMycobacterium、Acidfastness、G+、aerobe。Growthtorpidity,cultureneed4-6weeks.Typing:humantype、bovinetype、Birdtype、mousetype、mainhumantype。wayofinfection:respirationtract、digestivetrack、skinorplacenta.3第三页,共36页。Epidemiology1infectionsources:openpulmonarytuberculosis2routeoftransmission:byrespirationwayordigestiontract.3susceptiblepopulation4第四页,共36页。EpidemiologyThefactorsleadChildrenillwithTBContactTBamountsandtoxicity.powerofresistance.hereditaryfactor.5第五页,共36页。pathogenesybacterialnumber、toxicity、immunizationconditionCell-mediatedimmunereaction:macrophageswallowTB→antigenpresentationThandmacrophage→IL12→CD+4→TH1-IF-γ→topromotemononuclearcell;togather、activation、proliferationanddifferentiation→toproducealexinandoxidase、digestiveenzyme→tokillTB6第六页,共36页。pathogenesyIF-reinforcementCD+8、NKcellsactivitytophagocytosisTB.meanwhiletoleadhistoclasiadelayedallergy:Tcellmedia,macrophagetobeeffectorcell,tokillreinfectionTBandcausecheesynecrosisorholeformationAfterInfectionTB:primarydisease(5%),Secondarydisease(5%),nottofallillalllive(90%)7第七页,共36页。diagnoseObjectivetodiscoverfocal。Definitediseasecharacter、sizewhetherornotdeliverbacterium。8第八页,共36页。diagnose1historyTBtoxicsymptomtocontactTBpatientBCGvaccinationacuteinfection:measles,pertussisSupersensitivityerythemanodosum、exanthematousconjunctivitis。9第九页,共36页。diagnose2:OTtestagent:1/2000or1/10000PPDdose:0.1ML(OT5U)(or1U)。position:leftforearmpalmarisbelow1/3Infuseintracutaneousform6-10mmhillock。48~72hrobservationreaction。10第十页,共36页。diagnosisreaction<5mm(-)≧5mm(+)10-19mm(++)≧20mm(+++)Superreaction:induration、vesic、localulceration(++++)。11第十一页,共36页。diagnosissignificancepositivereactionAfterBCGvaccinationOlderchildrenpositivereactionindicatetobeeverinfectedwithTBbefore。InfantneverBCGvaccinationindicatenewinfectionrecent。Strongpositivereaction

indicatethereisactivenessTB.。from(-)to(+)、from<10mmto>10mm,orincrease>6mmbyactivenessTB.。12第十二页,共36页。diagnosisnegativereactionneverinfectionTBfirstInfectTBduring4-8weeksfalsenegativereaction,immunefunctiontobepresseddown。WrongwithtestorPPDineffective13第十三页,共36页。diagnosisBCGVaccinationandnaturalinfectionpositivereactionconditionResultinfectionBCGvaccinationextent(10~15mm)(5~9mm)tochangeSlowly(7~10d)Faster

2~3ddurationtolastlifetimetolast3~4yearsformDeepred\hardRed\soft14第十四页,共36页。diagnosis3:laboratoryexamination(1)findTBspecimen:sputum、gastricjuice、、serouscavityliquid.method:smear、fluorescentstaining、BACTECsystem:culturefor2weeks,testmycobacteriametabolismproduction,todistinguishTBandatypical.mycobacteria.Ltuberclebacterium:mutationTB,form、construction、acid-faststainingdifferentfromcommonTB。Easypassingplacenta,therapeuticinefficacy。15第十五页,共36页。diagnosis(2)immunologyandmolecularbiologytestELISA(酶联免疫吸附试验)ELIEP(酶联免疫电泳技术)DNA探针PCR(聚合酶链式反应)线条DNA探针杂交试验ESR(血沉)。16第十六页,共36页。diagnosis4:chestX-RAYTodefinitefocusofinfectionposition、extent、category、activitycondition。Toevaluateandfollowuptherapeuticefficacy。CTmorecleartofindthefocus、extentandspreadcondition。5:bronchofiberscopycheck:todefiniteEndotrachealmembraneTBandtuberculosisoftrachebronchiallymphnodes。6:lymphnodepuncturesmearorlymphadenbiopsytodiagnosis。17第十七页,共36页。tuberculotherapygeneraltreatmentnutrition、totakearest。avoidingtocontactinfectiondisease。PrimarilyTBtreatmentinout-patientclinicandregularityreturnvisit。Reportepidemicsituation。18第十八页,共36页。tuberculotherapyTreatmen

targetTokillBacillustuberculosisinfocustopreventdisseminate。therapeuticprincipleearlytreatmentReasonabledosageCombinemedicineRegularitytakedrugtoinsistonwholecourseSegmentingtreatment.19第十九页,共36页。tuberculotherapyAnti-tuberculosisdrugsWholegermicide:inacidandalkali,exteriorandinteriorofcellcankillgerm。(INHRFP)Halfgermicide:inacidoralkalienvironmentkillcellinteriororexteriorTB,SM/PZAbacteriostatic:EMB(ethambutol)ETH(ethionamide)20第二十页,共36页。tuberculotherapynewantituberculosistoAntidrugresistantRifamate(containINH150mgRFP300mg)Rifater(INH,RFPPZA)olddrugderivant:RifapentineNewchemicals:Dipasic,todelayresistantINHdrugstandardtreatment:refertoasymptomaticprimarilypulmonarytuberculosisusage:INH+RFP±EMBcourseoftreatment9~12month.21第二十一页,共36页。化疗方案Twostagetherapyreferto:activenessprimarilypulmonaryTB:acutemiliarytuberculosis;brainTB;intensificationtherapy:(purpose)Combination3~4germicidedrugsLonger3~4mo、shorter2mo。continuetreatmentstageCombinationtwodrugstokeeptherapeuticeffectfor12~18mo.(longerrang)or4mo.(Short-rang)。22第二十二页,共36页。化疗方案short-rangetherapyWHOimportantstrategytocuretuberculosismechanismofactionisfastkillorganisminnercelloroutcell。Tosputumbacterium(-),recoveryfast,recurrenceless。2HRZ/4HR、2SHRZ/4HR、2EHRZ/4HR23第二十三页,共36页。antituberculosisdrugsmedicine

dose

adversereaction

INH10~20多发性神经炎,肝损害RFP10~15可逆性肝损害,消化道症状。尿红色。PZA20-30肝损害,高尿酸血症。SM15~20听神经损害,肾损害。EMB15~20球后视神经炎。24第二十四页,共36页。Tuberculosispreventiontocontrolsourceofinfection:smear(+)patientPervasionBCGvaccination:tohaveaninoculationageisneonate.contraindicationcellularimmunitydeficiencyacuteinfectiousdiseaseconvalescencestageRegioneczemaorgeneralskindiseaseOT(+)25第二十五页,共36页。TuberculosispreventionDrugpreventionindication:1Closetocontactopenpulmonarytuberculosisinfamily2lower3yearsinfanthavenotinnoculationBCG;butOT(+)3OTfrom(-)to(+)recently4OT(+)withtoxicsymptom5OT(+)andrecentlyillwithmeaslesorpertussis6OT(+)needlong-termtotakecorticosteroidsorimmunodepressant26第二十六页,共36页。TuberculosispreventionApproach1:INH10mg/kgcourseoftreatment6~9mo.Approach2:INH+RFP(10mg/kg)course3mo.27第二十七页,共36页。原发性肺结核(primarypulmonarytuberculosis)首次侵入肺部发生的原发感染原发综合症(primarycomplex)原发病灶+局部病变淋巴结+淋巴管支气管淋巴结结核(胸腔内肿大淋巴结结核)28第二十八页,共36页。primarypulmonarytuberculosis病理部位:右侧肺上叶底部、下叶上部基本病变:渗出(炎症细胞单核细胞纤维蛋白)、增殖(结核结节结核肉芽肿)、坏死(干酪样坏死)。炎症特征:上皮样细胞结节、lange

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论